Expert Review of Clinical Immunology
Tofacitinib for the treatment of active ankylosing spondylitis in adults
Volume 18, Issue 3, March 2022.
Expert Review of Clinical Immunology
Safety of JAK inhibitors: focus on cardiovascular and thromboembolic events
Volume 18, Issue 3, March 2022.
Expert Review of Clinical Immunology
Recent issues in JAK inhibitor safety: perspective for the clinician
Volume 18, Issue 3, March 2022.
Expert Review of Clinical Immunology
Comparing available JAK inhibitors for treating patients with psoriasis
Volume 18, Issue 3, March 2022.
Expert Review of Clinical Immunology
Do JAK inhibitors have a realistic future in treating Crohn’s disease?
Volume 18, Issue 3, March 2022.